You are here

  • Home
  • Archive
  • Volume 3, Issue 2
  • Correction: Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis

Article Text

Article menu

See original article:

Download PDFPDF

XML
Correction
Correction: Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis

http://dx.doi.org/10.1136/bmjno-2020-000096corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Karunaratne K, Ahrabian D, Monoghan B, et al. Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis. BMJ Neurol Open 2021;3:e000096. doi:10.1136/bmjno-2020-000096

    The article has been corrected since it was first published. The published version misspelled one of the authors’ names as ‘Bernadette Monoghan’ which has been now amended to ‘Bernadette Monaghan’.